MAZE Maze Therapeutics, Inc. - Common Stock

NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗
$25.36
Price · May 20, 2026
Fundamentals as of May 12, 2026

MAZE Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$25.36
Market Cap
$2.04B
P/E (TTM)
-13.6
EPS (TTM)
$-3.05
Revenue (TTM)
$168M
Div Yield
ROE
-598.9%
Debt/Equity
52W Range
$10 – $54

MAZE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $168M
2024-12-31 2024-12-31
EPS $-3.05
2-point trend, -344.0%
2024-12-31 2025-12-31
Free Cash Flow $-113M
2025-12-31 2025-12-31
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
MAZE
Peer Median
P/E (TTM)
-13.6
22.4
P/B
5.8
4.6
Price / FCF
-18.1

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
MAZE
Peer Median
ROA
-41.1%
-7.1%
ROE
-598.9%
-18.6%
ROIC
-40.3%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
MAZE
Peer Median
Current Ratio
15.5
3.9
Quick Ratio
15.2

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
MAZE
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
MAZE
Peer Median
EPS (Diluted)
2-point trend, -344.0%
$-3.05

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
MAZE
Peer Median

MAZE Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 12 analysts
  • Strong Buy 5 41.7%
  • Buy 6 50.0%
  • Hold 1 8.3%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

11 analysts · 2026-05-16
Median target $56.00 +120.8%
Mean target $63.00 +148.4%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-3.1%
Period EPS Actual EPS Est Surprise
March 31, 2026 $-0.45 $-0.56 0.11%
Dec. 31, 2025 $-0.65 $-0.73 0.08%
Sept. 30, 2025 $-0.66 $-0.72 0.06%
June 30, 2025 $-0.77 $-0.87 0.10%
March 31, 2025 $-1.15 $-0.77 -0.38%
Dec. 31, 2024 $-18.32 $0.46 -18.8%

Peer Comparison Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
MAZE $2.04B -13.6 -598.9%
INVA 6.1 14.7%
NUVB $3.03B -14.9 699.0% -325.3% -60.3%
ATAI $223M -1.4 -1.9% -48464.0% -83.1%
MBX $1.42B -13.3 -29.6%
AMLX $1.33B -7.9 -77.1% -61.2%
PAHC 21.5 27.4% 3.7% 17.8% 30.9%
SEPN $1.25B -25.3 4174.5% -106.4% -12.9%
HROW $1.82B -350.0 36.4% -1.9% -8.4% 75.0%
COLL $1.47B 26.8 23.6% 8.1% 23.5% 59.4%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 13
Annual Income Statement data for MAZE
Metric Trend 20252024
Revenue · $168M
R&D Expense 2-point trend, +29.9% $108M $83M
SG&A Expense 2-point trend, +30.4% $34M $26M
Operating Expenses 2-point trend, +30.0% $143M $110M
Operating Income 2-point trend, -348.1% $-143M $58M
Pretax Income 2-point trend, -345.5% $-131M $53M
Income Tax 2-point trend, -100.0% $0 $1M
Net Income 2-point trend, -351.0% $-131M $52M
EPS (Basic) 2-point trend, -314.8% $-3.05 $1.42
EPS (Diluted) 2-point trend, -344.0% $-3.05 $1.25
Shares (Basic) 2-point trend, +1693.6% 42,976,024 2,396,094
Shares (Diluted) 2-point trend, +1474.0% 42,976,024 2,730,299
EBITDA $-143M ·
Balance Sheet 20
Annual Balance Sheet data for MAZE
Metric Trend 20252024
Cash & Equivalents 2-point trend, -3.8% $189M $197M
Short-term Investments $153M ·
Prepaid Expense 2-point trend, +60.5% $8M $5M
Current Assets 2-point trend, +73.4% $350M $202M
PP&E (Net) 2-point trend, -24.4% $5M $7M
PP&E (Gross) 2-point trend, +3.1% $24M $24M
Accum. Depreciation 2-point trend, +13.9% $19M $17M
Other Non-current Assets 2-point trend, -61.2% $3M $8M
Total Assets 2-point trend, +65.1% $397M $241M
Accounts Payable 2-point trend, -7.5% $2M $2M
Current Liabilities 2-point trend, +9.1% $23M $21M
Capital Leases 2-point trend, -15.8% $19M $22M
Other Non-current Liabilities 2-point trend, +12.9% $1M $969.0K
Total Liabilities 2-point trend, -3.4% $42M $44M
Common Stock 2-point trend, +2350.0% $49.0K $2.0K
Paid-in Capital 2-point trend, +1687.3% $844M $47M
Retained Earnings 2-point trend, -36.6% $-490M $-358M
Stockholders' Equity 2-point trend, +214.1% $355M $-311M
Liabilities + Equity 2-point trend, +65.1% $397M $241M
Shares Outstanding 2-point trend, +1916.3% 49,335,551 2,446,864
Cash Flow 7
Annual Cash Flow data for MAZE
Metric Trend 20252024
Stock-based Comp 2-point trend, +70.0% $16M $10M
Operating Cash Flow 2-point trend, -247.4% $-112M $76M
CapEx 2-point trend, -30.8% $794.0K $1M
Investing Cash Flow 2-point trend, -14805.1% $-171M $-1M
Financing Cash Flow 2-point trend, +196.5% $275M $93M
Taxes Paid · $1M
Free Cash Flow $-113M ·
Profitability 3
Annual Profitability data for MAZE
Metric Trend 20252024
ROA -41.1% ·
ROE -598.9% ·
ROIC -40.3% ·
Liquidity & Solvency 2
Annual Liquidity & Solvency data for MAZE
Metric Trend 20252024
Current Ratio 15.5 ·
Quick Ratio 15.2 ·
Per Share 4
Annual Per Share data for MAZE
Metric Trend 20252024
Book Value / Share $7.19 ·
Cash Flow / Share $-2.60 ·
Cash / Share $3.84 ·
EPS (TTM) 2-point trend, -344.0% $-3.05 $1.25
Valuation (TTM) 9
Annual Valuation (TTM) data for MAZE
Metric Trend 20252024
Revenue TTM · $168M
Net Income TTM 2-point trend, -351.0% $-131M $52M
Market Cap $2.04B ·
P/E -13.6 ·
P/B 5.8 ·
P / Tangible Book 5.8 ·
P / Cash Flow -18.3 ·
P / FCF -18.1 ·
Earnings Yield -7.4% ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-31
Revenue $168M
Net Income $-131M$52M
Diluted EPS $-3.05$1.25
Balance Sheet
2025-12-312024-12-31
Current Ratio 15.5
Quick Ratio 15.2
Cash Flow
2025-12-312024-12-31
Free Cash Flow $-113M

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.